Form 4 for RXST RxSight, Inc.

Accepted 2023-01-23 00:00:00 ET · period of report 2023-01-19 · accession 0001209191-23-004409 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-01-23	2023-01-19	RXST	Fountain Tamara	Dir	A - Grant	$0.00	+23.5K	19.2K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-19	A	A	4,312	$0.00	23,508	D	—	—	(F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. (F3) Subject to the Reporting Person's continuing as an Outside Director through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean January 19, 2023.
2	Common	Common Stock	2023-01-19	A	A	19,196	$0.00	19,196	D	—	—	(F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. (F2) Subject to the Reporting Person's continuing service as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of January 2, 2022. Consequently, one third of the RSUs subject to the award were settled immediately upon the date of grant.